“In the past year, the idea of a “polypill” combining several cheap, well-tested heart drugs has gained momentum, although it still has its critics. … But some question whether a pop-a-pill mentality should be encouraged, and many cardiologists are sharply critical of the potential risks inherent in one-size-fits-all treatment of patients who are not at risk.”
I’m thinking more a personalized poly-pill. Indeed, multi-drug interactions don’t seem to be studied enough. Though I think there’s an opportunity here.
